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Abstract
Background: The foodborne, gram-positive pathogen, Listeria monocytogenes, is capable of causing
lethal infections in compromised individuals. In the post genomic era of L. monocytogenes research,
techniques are required to identify and validate genes involved in the pathogenicity and
environmental biology of the organism. The aim here was to develop a widely applicable method
to tag L. monocytogenes strains, with a particular emphasis on the development of multiple strain
competitive index assays.
Results: We have constructed a new site-specific integrative vector, pIMC, based on pPL2, for the
selection of L. monocytogenes from complex samples. The pIMC vector was further modified
through the incorporation of IPTG inducible markers (antibiotic and phenotypic) to produce a suite
of four vectors which allowed the discrimination of multiple strains from a single sample. We were
able to perform murine infection studies with up to four EGDe isolates within a single mouse and
showed that the tags did not impact upon growth rate or virulence. The system also allowed the
identification of subtle differences in virulence between strains of L. monocytogenes commonly used
in laboratory studies.
Conclusion: This study has developed a competitive index assay that can be broadly applied to all
L. monocytogenes strains. Improved statistical robustness of the data was observed, resulting in
fewer mice being required for virulence assays. The competitive index assays provide a powerful
method to analyse the virulence or fitness of L. monocytogenes in complex biological samples.
Background
Historically, the measurement of bacterial virulence has
involved the use of infection models to access the ability
of a pathogen to cause disease. One widely used method
is the LD50 assay, which is defined as the number of bac-
teria required to kill 50% of the infected hosts. This
method yields valuable data pertaining to the cumulative,
absolute virulence of the bacterium, which can theoreti-
cally be compared between laboratories. But as detailed
by Beuzón and Holden [1], it is a crude method as it does
not relay information on the infection kinetics. Also, if the
deletion of a gene does not increase the LD50, it does not
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necessarily mean that the gene product does not play a
role in the virulence of the bacterium. If two or more
strains (e.g. wild type to mutant or independent isolates)
could be compared within a single host, the kinetics of
infection could be monitored, which could expose subtle
differences. Intra-animal experiments would help to min-
imise inherent inter-animal biological variation and also
improve the identification of mutations or isolates with
reduced competitive fitness within the host [2]. This form
of assay has been termed a "competitive index" and is
becoming an increasing popular method to examine bac-
terial virulence [3-5]. One crucial factor is to establish the
ability to discriminate strains, without adversely impact-
ing on the natural fitness of the organism.
Listeria monocytogenes is a foodborne pathogen, which can
cause fatal infections in a susceptible host [6]. In humans,
the initial step of gastrointestinal invasion is mediated via
the interaction of a bacterial cell surface exposed protein,
Internalin A (InlA), with the host cell surface ligand, E-
cadherin [7]. Subsequent intracellular replication and
spread can lead to systemic disease. While the mouse is a
poor model of listerial gastrointestinal disease due to the
limited affinity of InlA for murine E-cadherin, the tools
required for systemic proliferation are functional once the
gastrointestinal tract is bypassed via intravenous or intra-
peritoneal injection [8]. Identification and assessment of
genes required for the virulence of L. monocytogenes has
been greatly helped by the sequencing of multiple
genomes [9,10]; however, functional post genomic analy-
sis requires the development of improved techniques for
the discrimination of virulence potential. LD50 measure-
ments are still widely used, but for the reasons described
above, competitive indices could provide a more elegant
alternative. Even though competitive index assays have
been previously applied to L. monocytogenes [11-13], these
are not broadly applicable and have inherent limitations
(see Discussion section).
Here, we have established a method to stably tag L. mono-
cytogenes  strains and assess their competitive fitness in
complex samples. Through the development of a new site-
specific integrative vector, pIMC, we have produced four
derivatives with different IPTG inducible antibiotic and
phenotypic markers for their subsequent discrimination
from complex samples.
Results
Construction of pIMC
We have modified the Listeria site-specific integrative vec-
tor, pPL2 [11], by a series of SOE-PCR reactions to gener-
ate pIMC (Fig 1a). The backbone of pPL2 was conserved,
including the pBluescriptII KS multiple cloning site, low
copy E. coli origin of replication, conjugative transfer func-
tions, and the listerial phage integrase genes. To improve
antibiotic selection and decrease vector size, the gram-
negative cat gene was deleted and the inducible gram-pos-
itive cat promoter [12] replaced with the highly expressed
listerial promoter (Phelp) [13]. As shown in Fig 1b, L.
monocytogenes strain EGDe, when transformed with pPL2,
exhibited variable colony size and took 48 h to yield col-
Plasmid maps for pIMC and IPTG inducible marker expres- sion in pIMC3 Figure 1
Plasmid maps for pIMC and IPTG inducible marker 
expression in pIMC3. The plasmid (A) pIMC was created 
by SOE PCR (see Material and Methods) from oligonucle-
otides described in Table 1. The backbone of pIMC, derived 
from pPL2 [11] encodes the p15A low copy E. coli origin of 
replication and RP4 conjugative origin of transfer. No gram-
positive origin of replication is present on the plasmid, there-
fore upon transformation, chromosomal integration into L. 
monocytogenes tRNAARG is directed by the Listeriophage PSA 
integrase. Antibiotic selection is supplied by the chloram-
phenicol acetytransferase (cat) fused to the highly expressed 
listerial promoter (Phelp) [13]. Restriction sites labelled on 
pIMC are unique and for sequencing purposes, T3 and T7 
primer binding sites are present before the KpnI and after the 
SacI restriction sites, respectively. The plasmid sequence is 
accessible under the EMBL nucleotide accession number 
AM940001. A comparison of chloramphenicol selection (7.5 
μg/ml) is shown in (B), with pIMC exhibiting uniform colony 
size compared to pPL2 transformed EGDe. (C) Antibiotic 
markers (kanamycin (aphA3), erythromycin (ermAM) and tet-
racycline (tetM)) and the beta-glucuronidase marker (gusA) 
were subcloned from pIMK3 into pIMCa as a SacI/PstI frag-
ment (see Materials and Methods).BMC Microbiology 2008, 8:96 http://www.biomedcentral.com/1471-2180/8/96
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onies. Even upon passage in the presence of chloram-
phenicol, EGDe::pPL2 yielded a variable colony size and
could not grow at chloramphenicol concentrations above
7.5 μg/ml (data not shown). These results suggested that
the inducible gram-positive cat gene, as a single copy on
the chromosome, was a poor selection marker [12]. In
contrast, EGDe transformed with pIMC yielded uniformly
sized colonies, which were visible after 20 h (Fig 1b).
EGDe::pIMC exhibited similar growth kinetics to EGDe
and was able to grow in the presence of up to 75 μg/ml of
chloramphenicol. The integration of pIMC in EGDe and
two additional L. monocytogenes strains (10403S and
F2365) was highly stable. After 10 serial passages at 37°C
in BHI broth (1:1000 dilution) without antibiotic selec-
tion, none of the 100 colonies screened from each strain
had lost the plasmid. This vector should prove useful for
genetic complementation and as a marker for in vitro and
in vivo strain selection.
Development of in vivo multiple competitive index assay
Comparative analysis of virulence potential is a corner-
stone in understanding the ability of a pathogen to cause
disease and in determining the relative contribution of
putative virulence factors. We applied pIMC to establish a
widely applicable method to evaluate virulence potential
during mixed infections, in the form of a competitive
index (CI) [1]. To exploit the high level of chlorampheni-
col resistance of pIMC, which allows selection from com-
plex samples, we subcloned three IPTG-inducible
antibiotic resistance markers ermAM  (EryR),  aphA3
(KanR),  tetM  (TetR) and an IPTG-inducible phenotypic
marker, gusA (Gus) into pIMCa (see Material and Meth-
ods). These markers enable strains to be distinguished
directly from each other by antibiotic selection or through
X-gluc hydrolysis (leading to a blue colony colour). These
plasmids were electroporated into EGDe and the resultant
strains were evaluated in vitro for growth rate and in vivo
for virulence. No differences in growth rate were observed
between the strains when grown in BHI (data not shown).
In the initial in vivo experiments, the four EGDe tagged
strains were mixed at a 1:1:1:1 ratio and then adminis-
tered by intravenous injection to 15 BALB/c mice. On
each subsequent day, 5 mice were sacrificed, with the bac-
terial loads in the spleen and liver enumerated. Total
counts recovered from the spleen and liver throughout a
three day time course were consistent with a typical EGDe
infection (Fig 2a and data not shown), suggesting the tag-
ging and marker expression do not impact on the viru-
lence of EGDe. We were able to distinguish the four
tagged strains with a double selection, using both chlo-
ramphenicol and an additional marker for selection or
discrimination. We found that chloramphenicol at a con-
centration of 7.5 μg/ml was sufficient to remove back-
ground host bacterial flora on BHI agar from mouse faecal
and intestinal samples. Counts from both organs indi-
cated that each strain maintained a competitive index
close to 1.0 (Fig 2b), thereby maintaining the original
Growth kinetics within Balb/c mice after quadruple intrave- nous infection with EGDe::pIMC3 derivatives Figure 2
Growth kinetics within Balb/c mice after quadruple 
intravenous infection with EGDe::pIMC3 derivatives. 
(A) A tail vein injection with L. monocytogenes isolate EGDe 
was administered into 15 Balb/c mice with a total inoculum 
of 2 × 104 CFU per 100 μl. The inoculum was composed of 
an equal ratio of EGDe wt (5 × 103 CFU) tagged with the four 
different pIMC3 plasmids. On each subsequent day, 5 mice 
were sacrificed, with the spleens and livers enumerated on 
different BHI agars as described in the materials and meth-
ods. Bars correspond to EGDe; green (::pIMC3kan), red 
(::pIMC3ery), grey (::pIMC3tet) and blue (::pIMC3gus). Data 
are presented as mean CFU with standard deviation from 
five organs. The relative virulence ratio (RVR) (B) was calcu-
lated from the data presented in (A). Per mouse, the propor-
tion of each strain comprised within the organ (liver or 
spleen) (output %) was divided by the proportion of the 
strain in the initial inoculum (input %) and presented as an 
individual data point (using the formula in additional file 2). 
The mean RVR was calculated from the average of 5 organs 
from each strain. A value of 1 indicates no change in the rela-
tive ratio. Symbols correspond to EGDe; green circle 
(::pIMC3kan), red diamond (::pIMC3ery), grey triangle 
(::pIMC3tet) and blue square (::pIMC3gus). (C) A tail vein 
infection with L. monocytogenes isolate EGDe was adminis-
tered into 15 Balb/c mice with a total inoculum of 2 × 104 
CFU per 100 μl. The inoculum was composed of EGDe wt 
tagged with pIMCkan (0.75%), pIMCery (2.75%), pIMCtet 
(13.25%) and pIMCgus (83.25%) in a skewed ratio. The 
number on each bar gives the mean percentage for each 
strain recovered from the spleen or liver. Bars correspond 
to EGDe; green (::pIMC3kan), red (::pIMC3ery), grey 
(::pIMC3tet) and blue (::pIMC3gus).BMC Microbiology 2008, 8:96 http://www.biomedcentral.com/1471-2180/8/96
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inoculum ratio within each mouse. This demonstrates
that none of the four markers had an adverse impact on
virulence. The kinetics of infection through the IV route
revealed that the spleen was more permissive to initial
infection than the liver, consistent with the results of
other researchers [14]. In a second experiment, we tested
whether the ratios would be maintained throughout an
infection if the composition of the initial inoculum was
skewed (83.3(gus):13.2(tet):2.75(ery):0.75(kan)). As
before, ratios were maintained throughout the course of
the infection (Fig 2c). The Gus tagged strain is discrimi-
nated by a colourimetric change, which is not directly
selective and thus may be overlooked at very low recovery
rates (e.g. if virulence has been dramatically affected). The
other three markers have the advantage of clean selection;
however if four strains are required, we recommend that
the dominant strain (e.g. the wild type) should be tagged
with this marker.
Virulence comparison of different L. monocytogenes 
strains
Finally, we tested three genome-sequenced L. monocy-
togenes strains in a 1:1:1 infection; namely EGDe (KanR)
10403S (EryR) and F2365 (TetR), to examine the kinetics
of the individual strain infection and obtain information
on the relative virulence of these commonly used labora-
tory strains. We observed differences in the multiplication
of each strain within the organs analysed, with counts of
EGDe predominating in both the spleen and liver over the
other two strains (Fig 3a). By day 3 in the liver, EGDe out-
competed 10403S, while 10403S was recovered in signif-
icantly higher levels than F2365. In almost all cases, the
relative virulence ratio method (RVR) resulted in greatly
improved statistical validity when compared to the use of
raw CFU data (Fig 3b). This was especially true for organ
counts after 72 hours, where a large degree of variation in
the infection of livers and spleens was observed. However,
when relative ratios were examined, the increased statisti-
cal robustness of the data resulted in easier identification
of significant differences. The RVR can only be calculated
when strains are mixed within a single mouse and relative
ratios are calculated. An absolute value for the ability to
compete is presented in Fig 3c, as the competitive index of
each strain relative to EGDe. Here we show that in the
spleen after 48 h, both 10403S and F2365 exhibit signifi-
cantly reduced loads when compared to EGDe, with this
margin narrowed at 72 h. In the livers, F2365 was signifi-
cantly impaired throughout the three day time course
compared to both EGDe and 10403S. Taken together,
these results show that the number of bacteria present in
the organs at 72 h can be ranked as follows; spleen –
EGDe > 10403S = F2365 and liver – EGDe > 10403S >
F2365.
Growth kinetics within Balb/c mice after IV infection with  three L. monocytogenes strains Figure 3
Growth kinetics within Balb/c mice after IV infection 
with three L. monocytogenes strains. (A) A tail vein 
injection containing an equal ratio of three L. monocytogenes 
strains (EGDe, 10403S and F2365) was administered into 15 
Balb/c mice with a total inoculum of 2 × 104 CFU per 100 μl. 
Each of the strains was tagged with a different antibiotic 
marker. On each subsequent day, 5 mice were sacrificed, 
with the spleens and livers enumerated on different BHI 
agars as described in the materials and methods. Bars corre-
spond to; green (EGDe::pIMC3kan), red (10403S::pIMC3ery) 
and grey (F2365::pIMC3tet). Data are presented as mean 
CFU per organ with standard deviation. Statistical analyses 
were conducted using the one sample T-test (see additional 
file 1) measuring the raw CFU differences between two 
strains to calculate the mean difference per organ over 5 
mice. The relative virulence ratio (RVR) (B) was calculated 
from the data presented in (A) as described in figure legend 
2. Symbols correspond to; green circle (EGDe::pIMC3kan), 
red diamond (10403S::pIMC3ery) and grey triangle 
(F2365::pIMC3tet). Statistical analyses were conducted using 
the one sample T-test measuring the RVR differences 
between two strains to calculate the mean difference of 5 
organs (see additional file 2). The calculated P-values are pre-
sented, with values below 0.05 considered significant (P < 
0.05 (*), P < 0.005 (**) and P < 0.0005(***)). (C) The com-
petitive index score relative to EGDe (set as 1) was calcu-
lated by dividing the percentage of the strain (10403S or 
F2365) within an organ by the percentage value obtained for 
EGDe. The CI score per organ were plotted (with the same 
symbols as in (B)) and the mean CI written below. A CI score 
of 1 denotes no difference in the virulence compared to 
EGDe (for CI calaulation see additional figure 3). Underlined 
scores denote were statistical significance from (B) was 
observed.BMC Microbiology 2008, 8:96 http://www.biomedcentral.com/1471-2180/8/96
Page 5 of 9
(page number not for citation purposes)
Discussion
Our prior experience with the pPL2 plasmid [15,16] indi-
cated that the chloramphenicol resistance expressed was
relatively low, therefore we were unable to directly select
L. monocytogenes out of complex samples. This could be
due to the inducible nature of gram-positive cat genes as
described by Lovett [12]. To circumvent the requirement
for induction of cat expression, we remodelled pPL2 to
decrease plasmid size and exchange the inducible cat pro-
moter for a highly expressed constitutive version. This
increased the MIC of the new vector, pIMC, ten-fold com-
pared to pPL2. The improved selection allows the isola-
tion of tagged L. monocytogenes from complex
environments such as intestinal contents or food samples.
Further development of pIMC involved the creation of a
suite of four vectors with diverse antibiotic and pheno-
typic markers to allow the discrimination of individual L.
monocytogenes isolates. These were used to establish a com-
petitive index assay to compare the relative fitness of L.
monocytogenes strains. The tags did not compromise the fit-
ness of the transformed strains as determined by growth
in complex media and by the maintenance of an initial
infection ratio through out a three day time course in
Balb/c mice. The method established allows the direct dis-
crimination of strains without post-enumeration manual
scoring, such as PCR or replica plating [17,18]. The intro-
duction of post enumeration scoring can introduce bias in
the discrimination of bacteria, as only a small sample size
is processed per organ. When samples can be directly enu-
merated, larger numbers can be analysed and the intro-
duction of human error reduced. Also, the IPTG inducible
promoter should help to decrease any potential conse-
quences of marker expression during competitive growth.
We also observed improved statistical robustness when
analysing data from competitively infected mice. We
found that ratios were maintained throughout the course
of infection (Fig 2b), suggesting that, as observed with Sal-
monella typhimurium [1], true replication of the inoculum
occurs rather than clonal expansion. The statistical signif-
icance was especially evident when data from the third
day post infection was analysed (Fig 3a). Large differences
in the CFU counts isolated from individual livers and
spleens were observed due to inherent variation in the
infection process and animal-animal variability. How-
ever, analysis of the ratio of strains demonstrated
improved statistical validity (Fig 3b). For the experiment
reported in Fig 3, 15 mice were used, whereas traditionally
45 mice would have been required if each strain were ana-
lysed individually. Therefore, using mixed infections,
fewer mice are required to produce better results, a power-
ful demonstration of the 'reduce and refine' principles.
Competitive index assays for L. monocytogenes have previ-
ously been described by two research groups. Auerbuch et
al [18] established a strain of L. monocytogenes (10403S)
tagged with Tn917 (EryR), which mimics wild type
10403S infections. This has been widely applied by
researchers using the 10403S strain [19-22]. However, the
assay developed is only applicable to 10403S, requires
further analysis post enumeration (i.e. patching of colo-
nies) and only allows the comparison of wild type to a
second unmarked strain. In 2006, a fluorescence based
method for the discrimination of L. monocytogenes strains
was established in a replicative plasmid system [23]. A
total of five fluorescent proteins were shown to be func-
tional, with three suitable for simultaneous use to distin-
guish strains (due to emission spectra). While the tagging
method is non-invasive, prolonged incubation is required
for chromophore maturation and in the absence of selec-
tive pressure, significant and variable plasmid loss was
observed, depending on the fluorescent marker used [23].
The authors also describe difficulty in discriminating large
virulence attenuations due to the non-selective nature of
the marker.
From the comparison of three commonly used laboratory
strains of L. monocytogenes, we observed distinct differ-
ences in the kinetics of infection. Upon re-examination of
the sequence of the inlB gene from F2365, it was shown to
encode a nonsense mutation leading to premature stop
codon in the gene [24]. This may help to explain the
impaired ability to establish infection within the liver
compared to the 10403S and EGDe, as InlB plays an
important role in liver colonization [8].
We have applied the competitive index experiments to in
vivo experiments, but it equally could be used in vitro to
examine growth or survival within both sterile and com-
plex systems. Additionally, we envisage the use of internal
controls in experiments, such as the comparison of
mutant, wild type and complemented mutant, or the dual
tagging of a wild type and two separate mutants in murine
or tissue culture assays (e.g. adhesion, invasion and/or
intracellular multiplication). We acknowledge that prob-
lems may be encountered in certain situations when com-
paring multiple strains in a single host, e.g. if a molecule
involved in quorum sensing complemented a virulence
defect or when the route of infection can be hijacked by a
defective competing strain [25]. Nonetheless, we believe
our protocol displays significant advantages over previ-
ously described methods and provides an additional tool
for use in infection biology.
Conclusion
We have established a method for the comparison of the
relative fitness of L. monocytogenes strains utilising a novel,
stable integrative plasmid, pIMC, based on the pPL2
phage integrase plasmid. This method allows for the selec-
tion and discrimination of up to four isolates from com-BMC Microbiology 2008, 8:96 http://www.biomedcentral.com/1471-2180/8/96
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plex samples, without the requirement for post-
enumeration processing. There were no detrimental
effects on virulence or growth rate of the L. monocytogenes
strains due to tag expression, as demonstrated by systemic
spread in a BALB/c mouse model similar to that seen with
a wild type strain. The utility of the method was demon-
strated through the direct comparison of virulence of
three commonly used L. monocytogenes strains (EGDe,
10403S and F2365). The data yielded improved statistical
robustness when the ratios were examined rather than the
cumulative CFU counts from spleens and livers. EGDe
was shown to predominate in the liver and spleen by day
three of infection compared to the other two strains.
F2365 exhibited similar kinetics to 10403S in spleen rep-
lication but was significantly impaired in the ability to
replicate within the liver when compared to both strains.
Table 1: Plasmids, Strains and Oligonucleotides
PLASMID 
Name Description Reference
pTV1-OK Temperature sensitive plasmid for the delivery of Tn917. 11 kb. EryR KanR.[ 3 3 ]
pNZ272 Lactococcal beta-glucuronidase (gusA) transcriptional fusion vector. 4.6 kb. CmR.[ 3 4 ]
pIMC Site-specific Listerial integrative vector. High-level CmR from Phelp driven expression. 4.6 kb. CmR. This study
pIMK3 Site-specific Listerial integrative vector. High level IPTG controlled gene expression. 7.5 kb. KanR.[ 2 7 ]
pIMC3kan Site-specific Listerial integrative vector. IPTG controlled expression of aphA-III ex pTV1-OK. CmR [33] This study
pIMC3gus Site-specific Listerial integrative vector. IPTG controlled expression of gusA ex pNZ272. CmR [34] This study
pIMC3ery Site-specific Listerial integrative vector. IPTG controlled expression of ermAM ex pTV1-OK. CmR [33] This study
pIMC3tet Site-specific Listerial integrative vector. IPTG controlled expression of tetM ex CH919. CmR [35] This study
BACTERIA
Listeria monocytogenes
EGDe Wild type 1/2a strain. Genome sequenced. [9]
10403S Wild type 1/2a strain. Genome sequenced. Broad Institute (MIT). [36]
F2365 Wild type 4b strain. Genome sequenced. [10]
EGDe::pIMC3kan EGDe transformed with pIMC3kan integrated at the tRNAARG. This study
EGDe::pIMC3gus EGDe transformed with pIMC3gus integrated at the tRNAARG. This study
EGDe::pIMC3ery EGDe transformed with pIMC3ery integrated at the tRNAARG. This study
EGDe::pIMC3tet EGDe transformed with pIMC3tet integrated at the tRNAARG. This study
10403S::pIMC3ery 10403S transformed with pIMC3ery integrated at the tRNAARG. This study
F2365::pIMC3tet F2365 transformed with pIMCtet integrated at the tRNAARG. This study
Other Bacteria
DH10B Wild type Escherichia coli. Used for routine cloning. Invitrogen
CH919 MG1363 Lactococcus lactis subsp. lactis containing Tn919. [36]
OLIGONUCLEOTIDE
Name 5'-3'a RE site
108 Phelp B REV CATGGGTTTCACTCTCCTTCTAC
181 CAT C FWD AAATGTAGAAGGAGAGTGAAACCCATGAACTTTAATAAAATTGATTTAGAC
203 MCS FWD AATTAACCCTCACTAAAGGGAAC
204 MCS REV GACGTCGTAATACGACTCACTATAGGGC
205 Back FWD AGTGAGTCGTATTACGACGTCCCAGGGCTTCCCGGTATCAAC
206 Phelp A FWD ATCCCATTATGCTTTGGCAGTTTATTC
209 CAT D REV ATAATGAGACAGAATTATGATGATCATATGTCAACTAACGGGGCAGG
211 Back REV CATATGATCATCATAATTCTGTCTCATTATATAAC
373 gusA FWD TATACCATGGTACGTCCTGTAGAAACCCCAACC NcoI
374 gusA REV ATATCTGCAGTTATTGTTTGCCTCCCTGCTGCGG PstI
385 aphA3 FWD TAATCCATGGCTAAAATGAGAATATCACCGGAATTG NcoI
386 aphA3 REV AAGCCTGCAGTTAAAGCTTTTTAGACATCTAAATCTAGG PstI
387 ermAM FWD ATATCCATGGACAAAAATATAAAATATTCTCAAAAC NcoI
388 ermAM REV ATATCTGCAGTTATTTCCTCCCGTTAAATAATAGATAAC PstI
408 tetM FWD ATATCCATGGAAATTATTAATATTGGAGTTTTAGC NcoI
409 tetM REV ATATCTGCAGTTAAGTTATTTTATTGAACATATATCG PstI
a Restriction sites are in bold typeBMC Microbiology 2008, 8:96 http://www.biomedcentral.com/1471-2180/8/96
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Methods
Strains, Antibiotics and Reagents
The bacterial strains, plasmids and oligonucleotides used
in this study are described in table 1. Escherichia coli and
Listeria monocytogenes were made electrocompetent using
the protocols of Sheng et al [26] and Monk et al [27]
respectively. E. coli was routinely cultured in Luria Bertani
broth and L. monocytogenes in brain heart infusion broth
(Oxoid) with shaking at 200 rpm. Broth media were solid-
ified with 1.5% agar (Merck). For antibiotic selection the
following concentrations (μg/ml) were used (E. coli-Ec, L.
monocytogenes-Lm): Erythromycin (Ery) (Ec) 250 (Lm) 5,
Chloramphenicol (Cm) (Ec) 10 (Lm) 7.5, Kanamycin
(Kan) (Ec/Lm) 50 and Tetracycline (Tet) (Ec/Lm) 10. For
the detection of beta-glucuronidase (Gus) activity, 5-
Bromo-4-chloro-3-indolyl-beta-D-glucuronic Acid,
Cyclohexylammonium Salt (X-gluc)(Calbiochem, Merck)
was dissolved in Dimethylformamide at 40 mg/ml and
was added to agar plates at 100 μg/ml. For the induction
of marker expression, IPTG was included in agar at a con-
centration of 1 mM (Calbiochem, Merck). Colony (2×
Master Mix, Promega) and high fidelity PCR (KOD Hot-
start DNA polymease, Merck) was performed as described
by Monk et al [27]. All reagents were purchased from
Sigma Aldrich unless otherwise stated.
Construction of pIMC: a site specific integrative plasmid
The site-specific integrative listeriophage vector, pPL2,
was modified by spliced overlap extension (SOE) PCR to
incorporate constitutive chloramphenicol selection and
decrease vector size. Initially three fragments were ampli-
fied: (A) pBluescriptII KS (+) multiple cloning site (MCS)
including T3 and T7 promoter primer binding sites
(IM203/204) (B) the pPL2 backbone from 1100 to 4585
([GenBank:AJ417449]) (IM205/211) and (C) the Phelp
promoter (from pPL2lux-Phelp) [13] fused to chloram-
phenicol acetyltransferase (cat) gene from pNZ8048 [28]
by SOE PCR (IM181/209 and IM206/108). Phelp is a chi-
meric construct containing an optimized consensus lacto-
coccal promoter PCP25 [29] joined to the 5' UTR of the L.
monocytogenes hlyA gene [30]. The MCS of pBluescriptII KS
(+) was joined to the backbone (1100 bp end) of pPL2 to
remove both cat  genes. The Phelp-cat  amplimer was
joined to the backbone (4585 end) of the previous PCR
product. The PCR product for pIMC (4581 bp) was gel
extracted and phosphorylated with T4 polynucleotide
kinase (New England Biolabs). The product was ligated
with LigaFAST rapid DNA ligation system (Promega) for
30 min at 22°C, transformed into DH10B with selection
on LBA containing Cm at 10 μg/ml. A single clone of
pIMC was fully sequenced and deposited under the acces-
sion number: [EMBL:AM940001]. The plasmid schematic
(Fig 1a) was drawn with the online plasmid drawing tool
[31] and exported as an .svg file on an iBook (Apple) from
the Opera web browser into Adobe Illustrator CS2
(Adobe) for further manipulation as an .svg file.
Competitive index assay constructs
The pIMK3 is a kanamycin version of pIMC [27] which
contains the gram-positive functional rrnB transcription
termination sequence up stream (AatII/SacI) of an IPTG
inducible promoter (SacI/NcoI). Located downstream of
the IPTG inducible promoter is the highly expressed
repressor, Phelp-lacI  (SalI/KpnI). The above AatII/KpnI
region was subcloned from pIMK3 into pIMC, producing
pIMCa. The genes for antibiotic markers tetM  from
CH919 genomic DNA [32], ermAM from pTV1-OK [33],
aphA3  from pTV1-OK [34] and the phenotypic marker
gusA  from pNZ272 [35] were cloned as NcoI/PstI frag-
ments into pIMK3 and confirmed phenotypically in E.
coli. The marker and promoter were then subcloned as
SacI/PstI fragments into the corresponding sites of pIMCa,
yielding pIMC3ery, pIMC3gus, pIMC3kan and pIMC3tet.
Constructs were transformed into L. monocytogenes gener-
ating strains: EGDe::pIMC3ery, EGDe::pIMC3gus,
EGDe::pIMC3kan, EGDe::pIMC3tet, 10403S::pIMC3ery
and F2365::pIMC3tet. The production of these constructs
took advantage of the high-level CAT expression from
pIMC to facilitate in vivo selection (from faecal/intestinal
samples) and allow the discrimination of genotypes by
inducible marker expression, when used in co-culture
experiments.
Competitive index assay experiments
Overnight cultures of the tagged strains were washed three
times with PBS and diluted back to an OD600 nm of 0.1 (1×
108 cfu/ml) (Biophotometer, Eppendorf). Cultures were
then subsequently mixed at ratios of 1:1:1:1,
83.3:13.2:2.75:0.75. (EGDe::pIMC3gus, EGDe::pIMC3tet,
EGDe::pIMC3ery and EGDe::pIMC3kan, respectively) or
1:1:1 (EGDe::pIMC3kan, 10403S::pIMC3ery  and
F2365::pIMC3tet, respectively) and diluted 1:500 to
obtain 2 × 105  cfu/ml. Fifteen specific-pathogen free
female BALB/c mice (aged 6–8 weeks; Harlan) were intra-
venously inoculated via tail vein with 100 μl of diluted
cells. The inoculum was enumerated on the following BHI
based agars (A) BHI only (B) Cm 7.5 + 1 mM IPTG + X-
gluc (C) Cm 7.5 + 1 mM IPTG + Kan (D) Cm 7.5 + 1 mM
IPTG + Erm (E) Cm 7.5 + 1 mM IPTG + Tet. For the com-
parison of EGDe, 10403S and F2365, X-gluc containing
agars were omitted. In preliminary experiments the incor-
poration of IPTG, X-gluc and Cm was shown not to
impact on the recovery of L. monocytogenes from organ
homogenates (data not shown). On days 1, 2 and 3 post
infection, five mice from each group were sacrificed and
spleens and livers aseptically removed. The organs were
homogenized in 5 ml of PBS, serially diluted and enumer-
ated on the agars described above. For the comparison of
EGDe, 10403S and F2365 agar (B) was omitted.
The comparison of the tagged strains' ability to compete
within a mouse was determined as follows: the CFU per
organ from each strain within a single mouse was dividedBMC Microbiology 2008, 8:96 http://www.biomedcentral.com/1471-2180/8/96
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by the cumulative total of the four strains (addition of each
single count) to obtain a ratio of each strain per organ. This
ratio was divided by the initial ratio of the inoculum to
obtain a relative virulence ratio (RVR). A RVR score of 1
denotes no change the ability to compete, e.g. for the com-
parison of EGDe, 10403S and F2365 the RVR scores were
represented relative to EGDe (set as 1), thus obtaining a
competitive index (CI) value. All procedures involving ani-
mals complied with relevant legislation and were approved
by the animal ethics committee at University College Cork.
Statistical analysis (One sample T-test, Microsoft Excel)
was applied to the raw CFU and RVR counts through the
calculation of CFU or ratio difference (e.g. strain 1 to
strain 2, strain 1 to strain 3 and strain 2 to strain 3) per
organ (n = 5). A Microsoft Excel spreadsheet is attached
for the calculation of the RVR and subsequent one sample
T-test of CFU and RVR (additional files 1, 2 and 3). Com-
petitive index was calculated relative to EGDe with the
RVR of 10403S and F2365 per organ divided by the RVR
of EGDe (additional file 3). The average CI from 5 organs
is presented in Fig 3c.
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